EP3539539
TABLET FORMULATIONS OF (+)-2-[1 -(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.6.2014EP published:
5.11.2025EP application number:
19152029.5
EPO information:
European Patent Register
Max expiry date:
15.6.2034
Title in English:
TABLET FORMULATIONS OF (+)-2-[1 -(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONELanguage of the patent:
English
Timeline
Today
16.6.2014EP application
5.11.2025EP Publication
Owner
Name:
Amgen (Europe) GmbHAddress:
Floor 6-8 Suurstoffi 22, 6343 Risch-Rotkreuz, CH
Inventor
Name:
PARIKH, Darshan, K.Address:
Bridgewater, NJ 08807, US
Name:
MENON, AnilAddress:
Martinsville, NJ New Jersey 08836, US
Name:
TUTINO, AnthonyAddress:
New Providence, NJ New Jersey 07974, US
Priority
Number:
201361835667 PDate:
17.6.2013Country:
US
Number:
201361840210 PDate:
27.6.2013Country:
US
Classification
Categories:
A61K 9/20, A61K 9/28, A61K 9/50, A61K 31/4035